·   Log in

Archive for May 11th, 2010

Abbott to market Zydus Cadila’s 24 generic products to 15 emerging markets

Tuesday, May 11, 2010 19:11

Zydus Cadila will license 24 branded generics to Abbott for 15 emerging markets.

This was posted under category: Featured, Industry  |  Read Full Story  |  0 Comments

Once-daily indacaterol + glycopyrronium inhaler for COPD reaches phase 3 trials: Sosei

Tuesday, May 11, 2010 18:46

QVA149, a once-daily, dry powder bronchodilator for inhalation by Novartis for the treatment of chronic obstructive pulmonary disease (COPD), is to begin phase 3 studies.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with:

Regorafenib to treat metastatic colorectal cancer in advanced patient studies:Bayer Schering Pharma

Tuesday, May 11, 2010 18:43

Regorafenib, an experimental drug to treat metastatic colorectal cancer by Bayer Schering Pharma, is currently in late phase human trials.

This was posted under category: Clinical Trials  |  Read Full Story  |  0 Comments
Tagged with: